Kantonsspital Olten - Solothurner Spitäler

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials

Phase

• Phase 22 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Norwegian University of Science and Technology1 trial
• Swiss Cancer Institute1 trial

Running trials

• Recruiting

  Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

  NCT07020065· Phase 2· Swiss Cancer Institute· Source

  Contact: Walter Mingrone, MD

• Active, not recruiting

  Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

  NCT03540420· Phase 2· Norwegian University of Science and Technology· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting